Randomized phase III trial exploring the use of long-acting release octreotide in the prevention of chemotherapy-induced diarrhea in patients with colorectal cancer: the LARCID trial.

Paulo M Hoff; Daniel F Saragiotto; Carlos H Barrios; Auro del Giglio; Anelisa K Coutinho; Aline C Andrade; Carolina Dutra; Nora M Forones; Mariangela Correa; Maria do Socorro O Portella; Vanessa Q Passos; Renata N Chinen; Brigitte van Eyll

首页> 外文期刊>Journal of Clinical Oncology >Randomized phase III trial exploring the use of long-acting release octreotide in the prevention of chemotherapy-induced diarrhea in patients with colorectal cancer: the LARCID trial.

【24h】

Randomized phase III trial exploring the use of long-acting release octreotide in the prevention of chemotherapy-induced diarrhea in patients with colorectal cancer: the LARCID trial.

机译：研究使用长效释放奥曲肽预防结肠直肠癌患者化疗引起的腹泻的随机III期试验：LARCID试验。

获取原文

获取原文并翻译 | 示例

获取外文期刊封面封底 >>

开具论文收录证明 >>

文献代查 >>

页面导航

摘要
著录项
相似文献
相关主题

摘要

This study could not prove the efficacy of octreotide LAR in the prevention of CID.

机译：这项研究不能证明奥曲肽LAR预防CID的有效性。

著录项

来源
《Journal of Clinical Oncology》 |2014年第10期|共6页
作者
Paulo M Hoff; Daniel F Saragiotto; Carlos H Barrios; Auro del Giglio; Anelisa K Coutinho; Aline C Andrade; Carolina Dutra; Nora M Forones; Mariangela Correa; Maria do Socorro O Portella; Vanessa Q Passos; Renata N Chinen; Brigitte van Eyll;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类
关键词

相似文献

外文文献
中文文献
专利

1. Randomized phase III trial exploring the use of long-acting release octreotide in the prevention of chemotherapy-induced diarrhea in patients with colorectal cancer: the LARCID trial. [J] . Paulo M Hoff, Daniel F Saragiotto, Carlos H Barrios, Journal of Clinical Oncology . 2014,第10期

机译：研究使用长效释放奥曲肽预防结肠直肠癌患者化疗引起的腹泻的随机III期试验：LARCID试验。
2. Aprepitant triple therapy for the prevention of chemotherapy-induced nausea and vomiting following high-dose cisplatin in Chinese patients: a randomized, double-blind, placebo-controlled phase III trial. [J] . Zhihuang Hu, Ying Cheng, Hongyu Zhang, Supportive care in cancer: official journal of the Multinational Association of Supportive Care in Cancer . 2014,第4期

机译：在中国大剂量顺铂后预防性瑞乐本三联疗法预防由化学疗法引起的恶心和呕吐：一项随机，双盲，安慰剂对照的III期临床试验。
3. Prospective, double-blind, placebo-controlled, multicenter, randomized phase III study with orally administered budesonide for prevention of irinotecan (CPT-11)-induced diarrhea in patients with advanced colorectal cancer. [J] . Karthaus M, Ballo H, Abenhardt W, Oncology: International Journal of Cancer Research and Treatment . 2005,第4a6期

机译：口服布地奈德预防，预防伊立替康（CPT-11）引起的大肠直肠癌腹泻的前瞻性，双盲，安慰剂对照，多中心，随机III期研究。
4. Prospective Randomized Clinical Study on the Necessity of Chemical Cleaning in Patients with Colorectal Cancer [C] . T. Hone, M. Ishizuka, K. Takagi, Asian Federation of Coloproctology . 2005

机译：直肠癌患者化学清洁必要性的预期随机临床研究
5. Hypotensive resuscitation versus standard fluid resuscitation for the management of trauma patients in hemorrhagic shock: The safety phase of a randomized controlled trial. [D] . Morrison, C. Anne. 2009

机译：低血压复苏与标准液体复苏在失血性休克中对创伤患者的处理：一项随机对照试验的安全性阶段。
6. Randomized phase III trial of APF530 versus palonosetron in the prevention of chemotherapy-induced nausea and vomiting in a subset of patients with breast cancer receiving moderately or highly emetogenic chemotherapy [O] . Ralph Boccia, Erin O’Boyle, William Cooper 2016

机译：APF530与帕洛诺司琼在预防中度或高度致呕性化疗的部分乳腺癌患者中化疗引起的恶心和呕吐的预防性随机III期试验
7. Randomized phase III trial of APF530 versus palonosetron in the prevention of chemotherapy-induced nausea and vomiting in a subset of patients with breast cancer receiving moderately or highly emetogenic chemotherapy [O] . 2016

机译：APF530与帕洛诺司琼在预防中度或高度致呕性化疗的部分乳腺癌患者中化疗引起的恶心和呕吐的预防性随机III期试验

Randomized phase III trial exploring the use of long-acting release octreotide in the prevention of chemotherapy-induced diarrhea in patients with colorectal cancer: the LARCID trial.

摘要

著录项

相似文献

相关主题

期刊订阅